Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C60779> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- NCIT_C60779 IAO_0000115 "The hydrochloride salt of a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated." @default.
- NCIT_C60779 NCIT_A32 NCIT_C1909 @default.
- NCIT_C60779 NCIT_A6 NCIT_C74547 @default.
- NCIT_C60779 NCIT_A7 NCIT_C17293 @default.
- NCIT_C60779 NCIT_A7 NCIT_C17322 @default.
- NCIT_C60779 NCIT_A7 NCIT_C17328 @default.
- NCIT_C60779 NCIT_NHC0 "C60779" @default.
- NCIT_C60779 NCIT_P106 "Pharmacologic Substance" @default.
- NCIT_C60779 NCIT_P107 "Pazopanib Hydrochloride" @default.
- NCIT_C60779 NCIT_P108 "Pazopanib Hydrochloride" @default.
- NCIT_C60779 NCIT_P175 "737754" @default.
- NCIT_C60779 NCIT_P207 "C1872226" @default.
- NCIT_C60779 NCIT_P210 "635702-64-6" @default.
- NCIT_C60779 NCIT_P319 "33Y9ANM545" @default.
- NCIT_C60779 NCIT_P322 "CTRP" @default.
- NCIT_C60779 NCIT_P322 "FDA" @default.
- NCIT_C60779 NCIT_P322 "GDC" @default.
- NCIT_C60779 NCIT_P325 "A drug that is used to treat kidney cancer and is being studied in the treatment of other types of cancer. It may prevent the growth of new blood vessels that tumors need to grow. It is a type of protein tyrosine kinase inhibitor and a type of antiangiogenesis agent." @default.
- NCIT_C60779 NCIT_P329 "476479" @default.
- NCIT_C60779 NCIT_P330 "476479" @default.
- NCIT_C60779 NCIT_P350 "C21H23N7O2S.HCl" @default.
- NCIT_C60779 NCIT_P366 "Pazopanib" @default.
- NCIT_C60779 NCIT_P375 "Pazopanib Hydrochloride" @default.
- NCIT_C60779 NCIT_P399 "476479" @default.
- NCIT_C60779 normalizedInformationContent "92.730304365937428" @default.
- NCIT_C60779 referenceCount "3" @default.
- NCIT_C60779 hasExactSynonym "5-((4-((2,3-Dimethyl-2h-Indazol-6-Yl)Methylamino)Pyrimidin-2-yl)Amino)-2-Methylbenzenesulfonamide Monohydrochloride" @default.
- NCIT_C60779 hasExactSynonym "GW786034B" @default.
- NCIT_C60779 hasExactSynonym "PAZOPANIB HYDROCHLORIDE" @default.
- NCIT_C60779 hasExactSynonym "Pazopanib Hydrochloride" @default.
- NCIT_C60779 hasExactSynonym "Pazopater" @default.
- NCIT_C60779 hasExactSynonym "Votrient" @default.
- NCIT_C60779 hasExactSynonym "pazopanib hydrochloride" @default.
- NCIT_C60779 inSubset NCIT_C116977 @default.
- NCIT_C60779 inSubset NCIT_C116978 @default.
- NCIT_C60779 inSubset NCIT_C128784 @default.
- NCIT_C60779 inSubset NCIT_C157711 @default.
- NCIT_C60779 inSubset NCIT_C157712 @default.
- NCIT_C60779 inSubset NCIT_C176424 @default.
- NCIT_C60779 inSubset NCIT_C177537 @default.
- NCIT_C60779 inSubset NCIT_C63923 @default.
- NCIT_C60779 type Class @default.
- NCIT_C60779 isDefinedBy ncit.owl @default.
- NCIT_C60779 label "Pazopanib Hydrochloride" @default.
- NCIT_C60779 subClassOf NCIT_C129824 @default.
- NCIT_C60779 subClassOf NCIT_C129825 @default.
- NCIT_C60779 subClassOf NCIT_C1404 @default.
- NCIT_C60779 subClassOf NCIT_C155727 @default.
- NCIT_C60779 subClassOf NCIT_C159198 @default.
- NCIT_C60779 subClassOf NCIT_C159199 @default.
- NCIT_C60779 subClassOf NCIT_C163758 @default.
- NCIT_C60779 subClassOf NCIT_C163953 @default.
- NCIT_C60779 subClassOf NCIT_C163999 @default.
- NCIT_C60779 subClassOf NCIT_C164035 @default.
- NCIT_C60779 subClassOf NCIT_C164037 @default.
- NCIT_C60779 subClassOf NCIT_C1742 @default.
- NCIT_C60779 subClassOf NCIT_C1908 @default.
- NCIT_C60779 subClassOf NCIT_C1909 @default.
- NCIT_C60779 subClassOf NCIT_C1967 @default.
- NCIT_C60779 subClassOf NCIT_C2189 @default.
- NCIT_C60779 subClassOf NCIT_C274 @default.
- NCIT_C60779 subClassOf NCIT_C471 @default.
- NCIT_C60779 subClassOf NCIT_C60779 @default.
- NCIT_C60779 subClassOf NCIT_C93259 @default.